AGOURA HILLS, Calif., Dec. 04, 2025 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (OTCQB: OTLC) 45% owned Joint Venture, Sapu Nano today…
Illumina's up-and-coming constellation innovation delivers accuracy, speed, and ease of use in trial by GeneDx Constellation outperformed orthogonal methods in…
HONG KONG, June 9, 2025 /PRNewswire/ -- In the fast-evolving cryptocurrency landscape, identifying high-quality assets while steering clear of hype-driven investments…